BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26687668)

  • 1. Serum levels of apoptosis-related markers (sFasL, TNF-a, p53 and bcl-2) in COPD patients.
    Kosacka M; Porębska I; Korzeniewska A; Rubinsztajn R; Grabicki M; Jankowska R; Batura-Gabryel H; Chazan R
    Pneumonol Alergol Pol; 2016; 84(1):11-5. PubMed ID: 26687668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of soluble Fas ligand in cachexic patients with COPD are higher than those in non-cachexic patients with COPD.
    Takabatake N; Arao T; Sata M; Inoue S; Abe S; Shibata Y; Kubota I
    Intern Med; 2005 Nov; 44(11):1137-43. PubMed ID: 16357450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.
    Calikoglu M; Sahin G; Unlu A; Ozturk C; Tamer L; Ercan B; Kanik A; Atik U
    Respiration; 2004; 71(1):45-50. PubMed ID: 14872110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic inflammation in patients with COPD and pulmonary hypertension.
    Joppa P; Petrasova D; Stancak B; Tkacova R
    Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.
    Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of apoptosis in scorpion envenomed children: its reflection on their outcome.
    Meki AR; Hasan HA; El-Deen ZM; Bakkar S
    Toxicon; 2003 Sep; 42(3):229-37. PubMed ID: 14559073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Bcl-2, caspase-9 and soluble FasL levels as perinatal markers in late preterm pregnancies with intrauterine growth restriction.
    Genç ŞÖ; Karakuş S; Çetin A; Çetin M; Doğan HO; Korgalı EÜ
    Turk J Pediatr; 2019; 61(5):686-696. PubMed ID: 32105000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients.
    Yang YM; Sun TY; Liu XM
    Chin Med J (Engl); 2006 Apr; 119(8):628-33. PubMed ID: 16635406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of p53 and soluble Fas ligand (sFasL) serum level concentration as indicators of apoptosis in serum of patients with benign and malignant primary follicular thyroid tumors].
    Kołomecki K; Maciaszczyk P; Stepień H; Cywiński J; Cielecka J; Stepień T; Kuzdak K
    Endokrynol Pol; 2006; 57(4):320-5. PubMed ID: 17006831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients].
    Yang YM; Sun TY; Liu XM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):625-8. PubMed ID: 16378116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and cell proliferation: correlation with BCL-2 and P53 oncoprotein expression in human hepatocellular carcinoma.
    EI-Emshaty HM; Saad EA; Toson EA; Abdel Malak CA; Gadelhak NA
    Hepatogastroenterology; 2014; 61(133):1393-401. PubMed ID: 25436317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus.
    Liphaus BL; Kiss MHB; Carrasco S; Palmeira P; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Clin Rheumatol; 2017 Dec; 36(12):2847-2852. PubMed ID: 28378099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers.
    Myśliwiec J; Okota M; Nikołajuk A; Górska M
    Adv Med Sci; 2006; 51():119-22. PubMed ID: 17357290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of 4-hydroxynonenal in assessment of chronic obstructive pulmonary disease severity].
    Liu H; Xu JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):758-61. PubMed ID: 23289993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Age related changes of soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases].
    Myśliwiec J; Okłota M; Nikołajuk A; Górska M
    Endokrynol Pol; 2007; 58(6):492-5. PubMed ID: 18205105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation.
    Nomura S; Ishii K; Inami N; Uoshima N; Ishida H; Yoshihara T; Kitayama H; Hayashi K
    Transpl Immunol; 2007 Nov; 18(2):115-21. PubMed ID: 18005854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 concentration and soluble FasL (sFasL) serum level as indicators of apoptosis in patients with benign and malignant thyroid tumors.
    Kolomecki K; Maciaszczyk P; Stepien H; Stepien T; Kuzdak K; Ulanska J
    Bratisl Lek Listy; 2005; 106(10):297-300. PubMed ID: 16541608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.